Irr-VACV-CTLA-4

N/A

Report date: 2025/03/20 15:11:26

Base Information

Drug NameIrr-VACV-CTLA-4
Drug Alias NameCTLA-4 checkpoint inhibitor (Genelux)anti-CTLA-4 mAb (Genelux)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenelux Corp
China Registration ClassN/A

Develop Information

Active CompaniesGenelux Corp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A